NO20055655L - Anvendelse av azetidinkarboksamidderivater i terapi - Google Patents
Anvendelse av azetidinkarboksamidderivater i terapiInfo
- Publication number
- NO20055655L NO20055655L NO20055655A NO20055655A NO20055655L NO 20055655 L NO20055655 L NO 20055655L NO 20055655 A NO20055655 A NO 20055655A NO 20055655 A NO20055655 A NO 20055655A NO 20055655 L NO20055655 L NO 20055655L
- Authority
- NO
- Norway
- Prior art keywords
- sup
- therapy
- azetidinecarboxamide
- derivatives
- aryl
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/397—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having four-membered rings, e.g. azetidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/12—Antidiarrhoeals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/34—Tobacco-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB0310057 | 2003-05-01 | ||
PCT/GB2004/001812 WO2004096209A1 (en) | 2003-05-01 | 2004-04-29 | The use of azetidinecarboxamide derivatives in therapy |
Publications (2)
Publication Number | Publication Date |
---|---|
NO20055655D0 NO20055655D0 (no) | 2005-11-30 |
NO20055655L true NO20055655L (no) | 2006-01-31 |
Family
ID=33397042
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20055655A NO20055655L (no) | 2003-05-01 | 2005-11-30 | Anvendelse av azetidinkarboksamidderivater i terapi |
Country Status (16)
Country | Link |
---|---|
US (1) | US20060276452A1 (zh) |
EP (1) | EP1617839B1 (zh) |
JP (1) | JP2006525297A (zh) |
KR (1) | KR20060017763A (zh) |
CN (1) | CN1780615A (zh) |
AT (1) | ATE398449T1 (zh) |
AU (1) | AU2004233644A1 (zh) |
BR (1) | BRPI0409959A (zh) |
CA (1) | CA2524245A1 (zh) |
DE (1) | DE602004014484D1 (zh) |
EA (1) | EA200501703A1 (zh) |
MX (1) | MXPA05011472A (zh) |
NO (1) | NO20055655L (zh) |
NZ (1) | NZ543322A (zh) |
WO (1) | WO2004096209A1 (zh) |
ZA (1) | ZA200508835B (zh) |
Families Citing this family (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NZ543016A (en) * | 2003-05-01 | 2009-03-31 | Vernalis Res Ltd | Azetidinecarboxamide derivatives and their use in the treatment of CB1 receptor mediated disorders |
EP1907384A2 (en) * | 2005-06-30 | 2008-04-09 | Prosidion Limited | Gpcr agonists |
WO2007003962A2 (en) * | 2005-06-30 | 2007-01-11 | Prosidion Limited | Gpcr agonists |
US20080027087A1 (en) * | 2006-02-21 | 2008-01-31 | Ampla Pharmaceuticals, Inc. | CB1 antagonists and inverse agonists |
RU2009108280A (ru) | 2006-08-08 | 2010-09-20 | Санофи-Авентис (Fr) | Ариламиноарилалкилзамещенные имидазолидин-2,4-дионы, способы их получения, содержащие эти соединения лекарственные средства и их применение |
EP2025674A1 (de) | 2007-08-15 | 2009-02-18 | sanofi-aventis | Substituierte Tetrahydronaphthaline, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel |
WO2010003624A2 (en) | 2008-07-09 | 2010-01-14 | Sanofi-Aventis | Heterocyclic compounds, processes for their preparation, medicaments comprising these compounds, and the use thereof |
WO2010068601A1 (en) | 2008-12-08 | 2010-06-17 | Sanofi-Aventis | A crystalline heteroaromatic fluoroglycoside hydrate, processes for making, methods of use and pharmaceutical compositions thereof |
WO2011023754A1 (en) | 2009-08-26 | 2011-03-03 | Sanofi-Aventis | Novel crystalline heteroaromatic fluoroglycoside hydrates, pharmaceuticals comprising these compounds and their use |
WO2011157827A1 (de) | 2010-06-18 | 2011-12-22 | Sanofi | Azolopyridin-3-on-derivate als inhibitoren von lipasen und phospholipasen |
US8828995B2 (en) | 2011-03-08 | 2014-09-09 | Sanofi | Branched oxathiazine derivatives, method for the production thereof, use thereof as medicine and drug containing said derivatives and use thereof |
EP2683700B1 (de) | 2011-03-08 | 2015-02-18 | Sanofi | Tetrasubstituierte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung |
EP2683698B1 (de) | 2011-03-08 | 2017-10-04 | Sanofi | Mit adamantan- oder noradamantan substituierte benzyl-oxathiazinderivate, diese verbindungen enthaltende arzneimittel und deren verwendung |
US8809324B2 (en) | 2011-03-08 | 2014-08-19 | Sanofi | Substituted phenyl-oxathiazine derivatives, method for producing them, drugs containing said compounds and the use thereof |
WO2012120054A1 (de) | 2011-03-08 | 2012-09-13 | Sanofi | Di- und trisubstituierte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung |
WO2012120055A1 (de) | 2011-03-08 | 2012-09-13 | Sanofi | Di- und trisubstituierte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung |
EP2683701B1 (de) | 2011-03-08 | 2014-12-24 | Sanofi | Mit benzyl- oder heteromethylengruppen substituierte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung |
WO2012120052A1 (de) | 2011-03-08 | 2012-09-13 | Sanofi | Mit carbozyklen oder heterozyklen substituierte oxathiazinderivate, verfahren zu deren herstellung, diese verbindungen enthaltende arzneimittel und deren verwendung |
WO2012120057A1 (de) | 2011-03-08 | 2012-09-13 | Sanofi | Neue substituierte phenyl-oxathiazinderivate, verfahren zu deren herstellung, diese verbindungen enthaltende arzneimittel und deren verwendung |
US11141404B1 (en) | 2020-11-18 | 2021-10-12 | Anebulo Pharmaceuticals, Inc. | Formulations and methods for treating acute cannabinoid overdose |
CA3234167A1 (en) | 2021-10-11 | 2023-04-20 | Joseph Fenton Lawler | Crystalline forms of a cannabinoid receptor type 1 (cb1) modulator and methods of use and preparation thereof |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4261990A (en) * | 1979-03-09 | 1981-04-14 | Ciba-Geigy Corporation | N-alkyleneiminoalkyl-dicarboximides as antiallergics and antiasthmatics |
JPH03264562A (ja) * | 1989-05-22 | 1991-11-25 | Hokuriku Seiyaku Co Ltd | ピペリジン誘導体 |
JP3194355B2 (ja) * | 1996-10-24 | 2001-07-30 | 宇部興産株式会社 | ピペリジン化合物及びその製法 |
DE69911373T2 (de) * | 1998-01-23 | 2004-07-01 | Vernalis Research Ltd., Winnersh | Azetidincarboxamidderivate zur behandlung von zns-erkrankungen |
GB9917386D0 (en) * | 1999-07-23 | 1999-09-22 | Cerebrus Ltd | Chemical compounds-II |
US6566356B2 (en) * | 2000-03-03 | 2003-05-20 | Aventis Pharma S.A. | Pharmaceutical compositions containing 3-aminoazetidine derivatives, novel derivatives and their preparation |
FR2805817B1 (fr) * | 2000-03-03 | 2002-04-26 | Aventis Pharma Sa | Compositions pharmaceutiques contenant des derives d'azetidine, les nouveaux derives d'azetidine et leur preparation |
FR2805810B1 (fr) * | 2000-03-03 | 2002-04-26 | Aventis Pharma Sa | Compositions pharmaceutiques contenant des derives de 3- amino-azetidine, les nouveaux derives et leur preparation |
NZ543016A (en) * | 2003-05-01 | 2009-03-31 | Vernalis Res Ltd | Azetidinecarboxamide derivatives and their use in the treatment of CB1 receptor mediated disorders |
-
2004
- 2004-04-29 WO PCT/GB2004/001812 patent/WO2004096209A1/en active IP Right Grant
- 2004-04-29 AU AU2004233644A patent/AU2004233644A1/en not_active Abandoned
- 2004-04-29 BR BRPI0409959-1A patent/BRPI0409959A/pt not_active IP Right Cessation
- 2004-04-29 DE DE602004014484T patent/DE602004014484D1/de not_active Expired - Fee Related
- 2004-04-29 EP EP04730286A patent/EP1617839B1/en not_active Expired - Lifetime
- 2004-04-29 CA CA002524245A patent/CA2524245A1/en not_active Abandoned
- 2004-04-29 AT AT04730286T patent/ATE398449T1/de not_active IP Right Cessation
- 2004-04-29 NZ NZ543322A patent/NZ543322A/xx unknown
- 2004-04-29 JP JP2006506193A patent/JP2006525297A/ja active Pending
- 2004-04-29 EA EA200501703A patent/EA200501703A1/ru unknown
- 2004-04-29 KR KR1020057020651A patent/KR20060017763A/ko not_active Application Discontinuation
- 2004-04-29 US US10/552,574 patent/US20060276452A1/en not_active Abandoned
- 2004-04-29 MX MXPA05011472A patent/MXPA05011472A/es active IP Right Grant
- 2004-04-29 CN CNA2004800117556A patent/CN1780615A/zh active Pending
-
2005
- 2005-10-31 ZA ZA200508835A patent/ZA200508835B/en unknown
- 2005-11-30 NO NO20055655A patent/NO20055655L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
CN1780615A (zh) | 2006-05-31 |
NZ543322A (en) | 2009-03-31 |
ATE398449T1 (de) | 2008-07-15 |
WO2004096209A1 (en) | 2004-11-11 |
CA2524245A1 (en) | 2004-11-11 |
US20060276452A1 (en) | 2006-12-07 |
EP1617839B1 (en) | 2008-06-18 |
KR20060017763A (ko) | 2006-02-27 |
AU2004233644A1 (en) | 2004-11-11 |
EP1617839A1 (en) | 2006-01-25 |
NO20055655D0 (no) | 2005-11-30 |
ZA200508835B (en) | 2006-12-27 |
JP2006525297A (ja) | 2006-11-09 |
EA200501703A1 (ru) | 2006-06-30 |
MXPA05011472A (es) | 2005-12-12 |
DE602004014484D1 (de) | 2008-07-31 |
BRPI0409959A (pt) | 2006-04-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20055655L (no) | Anvendelse av azetidinkarboksamidderivater i terapi | |
EA200501585A1 (ru) | Производные азетидинкарбоксамида и их применение при лечении нарушений, опосредованных св1 рецепторами | |
IS8502A (is) | Azatvíhringja heteróhringir sem kannabínóíð-viðtakastillar | |
ATE440603T1 (de) | 8-hydroxychinolinderivate | |
MX2009006742A (es) | Inhibidores acilaminopirazoles como fgfr. | |
EA201001669A1 (ru) | Замещенные пиримидин-5-карбоксамиды 281 | |
HRP20090281T1 (en) | 1,2,3,4-tetrasubstituted indole for the treatment of respiratory diseases | |
WO2005023759A3 (en) | Heterocyclic inhibitors of mek and methods of use thereof | |
CY1107974T1 (el) | Παραγωγα κινολινης και κιναζολινης εχοντα συναφεια προς τους υποδοχεις τυπου 5ht1 | |
MY140638A (en) | New heterocyclic compounds, which are active as inhibitors of beta-lactamases | |
IS2696B (is) | Setin 2-amínótetralín fyrir meðhöndlunina á geðdeyfð | |
NO20051263L (no) | Ny anvendelse av benzotiazolderivater | |
ATE384058T1 (de) | Thiazolderivate | |
ATE341550T1 (de) | Quinolinyl-pyrrolopyrazole | |
SE0401345D0 (sv) | Therapeutic compounds: Pyridine as scaffold | |
ATE307810T1 (de) | Imidazol-2-carbonsäureamid derivate als raf- kinase-inhibitoren | |
SE0402762D0 (sv) | Indazole sulphonamide derivatives | |
GEP20063751B (en) | 2-Acyl Indol Derivatives and Their Use as Anti-Tumour Agents | |
DE60045508D1 (de) | Dalda-analoge und ihre verwendung | |
ATE279192T1 (de) | Die verwendung eines benzimidazoles zur herstellung eines medikamentes zur krebsvorbeugung | |
SE0302573D0 (sv) | Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof | |
IL195016A0 (en) | 1h-indol-5-yl-piperazin-1-yl-methanone derivatives | |
TW200504029A (en) | Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof | |
MXPA05005790A (es) | Aminoalcoxiindoles como ligandos del receptor 5-ht6 para el tratamiento de enfermedades del sistema nervioso central. | |
MY139676A (en) | Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |